Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Certara Inc
(NQ:
CERT
)
13.29
+0.29 (+2.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Certara Inc
< Previous
1
2
3
4
5
Next >
Certara to Participate in Upcoming Investor Conferences
August 21, 2024
From
Certara
Via
GlobeNewswire
Certara Launches Phoenix™ Version 8.5 Drug Development Software
August 15, 2024
From
Certara
Via
GlobeNewswire
CERT Stock Earnings: Certara Misses EPS, Misses Revenue for Q2 2024
August 06, 2024
CERT stock results show that Certara missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Certara Reports Second Quarter 2024 Financial Results
August 06, 2024
Reiterates Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Decoding 4 Analyst Evaluations For Certara
April 04, 2024
Via
Benzinga
Analyst Scoreboard: 4 Ratings For Certara
March 01, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
July 09, 2024
From
Certara
Via
GlobeNewswire
Simulations Plus Stock Drops 15% Despite EPS Beat
July 05, 2024
Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
July 02, 2024
From
Certara
Via
GlobeNewswire
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
June 17, 2024
AI-enabled solutions accelerate regulatory and medical writing processes, enhancing quality, transparency, and efficiencies
From
Certara
Via
GlobeNewswire
Recap: Certara Q3 Earnings
November 08, 2023
Via
Benzinga
Certara to Participate in the Jefferies Global Healthcare Conference
May 29, 2024
From
Certara
Via
GlobeNewswire
Certara Appoints New Chief Human Resources Officer & General Counsel
May 21, 2024
From
Certara
Via
GlobeNewswire
CERT Stock Earnings: Certara Meets EPS, Beats Revenue for Q1 2024
May 07, 2024
CERT stock results show that Certara met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Certara Reports First Quarter 2024 Financial Results
May 07, 2024
Reiterates Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
The Latest Analyst Ratings for Certara
October 11, 2023
Via
Benzinga
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
April 16, 2024
From
Certara
Via
GlobeNewswire
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
April 09, 2024
From
Certara
Via
GlobeNewswire
Certara Reports Fourth Quarter 2023 Financial Results
February 29, 2024
Provides Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
February 01, 2024
From
Certara
Via
GlobeNewswire
Tax Season Is Here: Meet The New Federal Program That Can Eat Away At Tax Preparation Companies
January 30, 2024
New IRS program launching for free tax filing could affect tax prep companies like H&R Block and Intuit. Market share drop could impact ETFs.
Via
Benzinga
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
December 13, 2023
Combined organization establishes the life sciences industry’s largest quantitative systems pharmacology (QSP) center of excellence contributing to faster and more effective medicine development.
From
Certara
Via
GlobeNewswire
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
November 21, 2023
Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies
From
Certara
Via
GlobeNewswire
Certara Reports Third Quarter 2023 Financial Results
November 08, 2023
Reiterates Full Year 2023 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
October 11, 2023
From
Certara
Via
GlobeNewswire
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
September 19, 2023
Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelines
From
Certara
Via
GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
August 29, 2023
From
Certara
Via
GlobeNewswire
Certara Simcyp™ Group Awarded Two New Grants from US FDA
August 29, 2023
Programs focus on use of physiologically-based pharmacokinetic (PBPK) modeling for demonstrating virtual bioequivalence and predicting drug absorption of topical formulations
From
Certara
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
August 22, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.